Entradatx.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
95% 
Page quality
60% 
Page structure
68% 
Link structure
81% 
Server
54% 
External factors
100% 
SEO Score
Response time
1.45 s
File size
2,211.50 kB
Words
789
Media files
6
Number of links
73 internal / 21 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Entrada Therapeutics | Making Intracellular Therapeutics A Reality
The page title should be shorter than 580 pixels. It is 591 pixels long. Optimize title
There are no duplicate words in the title
Meta description
(Critically important)
Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.
The length of the meta description is perfect. (656 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.entradatx.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: United States of America
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width, initial-scale=1
turbo-cache-controlno-cache
generatorSEOmatic
descriptionOvercoming the challenge of intracellular target access to transform the treatment of devastating diseases.
referrerno-referrer-when-downgrade
robotsall
langen-us
twitter:cardsummary
twitter:creator@
twitter:titleEntrada Therapeutics | Making Intracellular Therapeutics A Reality
twitter:descriptionOvercoming the challenge of intracellular target access to transform the treatment of devastating diseases.
twitter:imagehttps://images.entradatx.com/production/images/phallika-in-lab.jpg?w=1200&h=630&q=82&fit=crop&dm=1710942705&s=c524799f84e381d313ed65703d6c252f
twitter:image:width1200
twitter:image:height630
twitter:image:altPhallika in lab doing research
og:localeen_US
og:site_nameEntrada Therapeutics
og:typewebsite
og:urlhttps://www.entradatx.com/
og:titleMaking Intracellular Therapeutics A Reality
og:descriptionOvercoming the challenge of intracellular target access to transform the treatment of devastating diseases.
og:imagehttps://images.entradatx.com/production/images/phallika-in-lab.jpg?w=1200&h=630&q=82&fit=crop&dm=1710942705&s=c524799f84e381d313ed65703d6c252f
og:image:width1200
og:image:height630
og:image:altPhallika in lab doing research
X-UA-CompatibleIE=edge
charsetutf-8

Test up to 1.000 webpages of entradatx.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
This page contains 789 words. That's ok.
30.8% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
11 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 15.82 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
The file size of the HTML document is very large (2211.5 kB).
A viewport "width=device-width, initial-scale=1" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 16 tags for this page.
Image SEO
(Somewhat important)
4 images have no alt attribute. The content of alt attributes is used by search engines.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
This page uses Google authorship information without an image.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...81624&s=5b1f09100feff2854451bb6d5f1e1e7eEntrada is making Intracellular Therapeutics A Reality
...84430&s=93b476e529713c9bf2a0f4ccc7dcb94cMax blowing bubbles
...47251&s=c38345ef0eef551245db0ffc0193562fNo alt attribute provided
...47294&s=cb0829448dedc4cfc2eef9c8d011617cNo alt attribute provided
...58509&s=b59efb5e31f81d6de78f14a4424aac86No alt attribute provided
/dist/assets/mass-econ-logo-e1a7a115.pngNo alt attribute provided

Page structure

H1 heading
(Critically important)
Making Intracellular Therapeutics A Reality
The H1 heading is perfect.
Headings
(Important)
Some headings occur twice on the page.
There are 36 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H1 Making Intracellular Therapeutics A Reality
H2 Recent News
H2 Our Mission
H2 Our Platform
H2 Our Pipeline
H2 Life at Entrada
H2 Notice
H2 Notice Duplicate text
H3 Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
H3 Entrada Therapeutics Reports Second Quarter 2024 Financial Results
H3 Entrada Therapeutics Announces $100 Million Registered Direct Offering
H3 More at Entrada
H4 About
H4 Leadership
H4 Social Responsibility
H4 Intracellular Therapeutics
H4 EEV™ Platform
H4 Broad Therapeutic Potential
H4 Pipeline
H4 Duchenne Muscular Dystrophy Program
H4 Myotonic Dystrophy Type 1 Program
H4 Manuscripts
H4 Presentations
H4 Patients
H4 DREAMS Grant Program
H4 Our Values
H4 Employee Benefits
H4 Open Positions
H4 Who We Are
H4 Platform
H4 Pipeline Duplicate text
H4 Careers
H4 Newsroom
H4 Get in Touch
H5 Featured
H5 Previous
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 21 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.entradatx.com/Anchor Skip to Main Content
https://www.entradatx.com/No Text
https://ir.entradatx.com/External Subdomain Investor Relations
https://www.entradatx.com/contactSubdomain Contact
/accessibilitySubdomain Accessibility
https://www.linkedin.com/compa...External Subdomain LinkedIn
https://www.entradatx.com/aboutSubdomain Who We Are
https://www.entradatx.com/aboutSubdomain About On a mission to treat devastating diseases with intracellular therapeutics
https://www.entradatx.com/aboutSubdomain Anchor Leadership Decades of experience in the development of therapeutics and expertise in rare diseases
https://www.entradatx.com/aboutSubdomain Anchor Social Responsibility Our values fuel our innovation
/platformSubdomain Platform
/platformSubdomain Intracellular Therapeutics Working to address the fundamental challenges of conventional intracellular therapeutics
/platformSubdomain Anchor EEV™ Platform Designed to engage disease-causing targets previously considered inaccessible and undruggable
/platformSubdomain Anchor Broad Therapeutic Potential Modular approach supports efficient expansion into multiple therapeutic areas
/pipelineSubdomain Pipeline
/pipelineSubdomain Pipeline We are creating a diverse and expanding portfolio of oligonucleotide, antibody and enzyme-based programs
https://www.entradatx.com/dmdSubdomain Duchenne Muscular Dystrophy Program Our programs represent a differentiated approach to developing potential treatments for patients with Duchenne
https://www.entradatx.com/dm1Subdomain Myotonic Dystrophy Type 1 Program Our second program offers a potentially innovative approach to reach the intracellular disease-causing target for patients ...
/manuscriptsSubdomain Publications
/manuscriptsView All
/manuscripts/Endosomal Escape Vehicle Platform Enhances the Delivery of Oligonucleotides in Preclinical Models of Neuromuscular Disorders
/manuscripts/Cell-Penetrating Peptides Escape the Endosome by Inducing Vesicle Budding and Collapse
/manuscripts/Understanding Cell Penetration of Cyclic Peptides
/manuscripts/Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides
/presentationsText duplicate View All
/presentations/The Endosomal Escape Vehicle Platform Enhances Lipid Nanoparticle-Mediated Delivery of Genomic Medicines
/presentations/Utility of a 3D–Engineered Skeletal Muscle Organoid System to Assess Exon Skipping, Dystrophin Protein Restoration, and Functional Improvement in a Human DMD...
/patientsSubdomain Patients
/patientsSubdomain Patients At Entrada, our efforts are guided by you – the people and families we are working to help
https://www.entradatx.com/dreamsSubdomain DREAMS Grant Program Learn more about our competitive grant program to advance diversity, equity, inclusion and accessibility
https://www.entradatx.com/careersSubdomain Careers
https://www.entradatx.com/careersSubdomain Anchor Our Values See the values that bind us together
https://www.entradatx.com/careersSubdomain Anchor Employee Benefits View our comprehensive and generous financial and wellness benefits
https://www.entradatx.com/careersSubdomain Anchor Open Positions Learning more about working at Entrada
https://www.entradatx.com/aboutSubdomain About
https://www.entradatx.com/aboutLeadership
https://www.entradatx.com/aboutSocial Responsibility
/platformSubdomain Intracellular Therapeutics
/platformEEV™
/platformTherapeutic Potential
/pipelineSubdomain Text duplicate Pipeline
https://www.entradatx.com/dmdSubdomain Duchenne Muscular Dystrophy
https://www.entradatx.com/dm1Subdomain Myotonic Dystrophy Type 1 Program
/manuscriptsSubdomain Manuscripts
/presentationsSubdomain Presentations
/patientsSubdomain Text duplicate Patients
https://www.entradatx.com/dreamsSubdomain DREAMS Grant Program
https://www.entradatx.com/careersOur Values
https://www.entradatx.com/careersEmployee Benefits
/careers/Open Positions
https://ir.entradatx.com/External Subdomain IR Home
https://ir.entradatx.com/news-...External Subdomain News Releases
https://ir.entradatx.com/eventsExternal Subdomain Events
https://ir.entradatx.com/prese...External Subdomain Text duplicate Presentations
https://ir.entradatx.com/stock...External Subdomain Stock Information
https://ir.entradatx.com/corpo...External Subdomain Corporate Governance
https://ir.entradatx.com/finan...External Subdomain Financial Information
https://ir.entradatx.com/inves...External Subdomain FAQs
https://ir.entradatx.com/email...External Subdomain Email Alerts
https://ir.entradatx.com/conta...External Subdomain Contact IR
https://www.linkedin.com/compa...External Subdomain Text duplicate LinkedIn
/accessibilitySubdomain Text duplicate Accessibility
/privacy-policySubdomain Privacy Policy
/terms-of-useSubdomain Terms of Use
https://www.entradatx.com/contactSubdomain Text duplicate Contact
https://www.entradatx.com/aboutSubdomain Text duplicate About
/pipelineSubdomain Text duplicate Pipeline
https://ir.entradatx.com/news-...External Subdomain Text duplicate View All
http://ir.entradatx.com/news-r...External Subdomain Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
http://ir.entradatx.com/news-r...External Subdomain Trivial anchor text
Read More
http://ir.entradatx.com/news-r...External Subdomain Entrada Therapeutics Reports Second Quarter 2024 Financial Results
http://ir.entradatx.com/news-r...External Subdomain Text duplicate Trivial anchor text
Read More
http://ir.entradatx.com/news-r...External Subdomain Entrada Therapeutics Announces $100 Million Registered Direct Offering
http://ir.entradatx.com/news-r...External Subdomain Text duplicate Trivial anchor text
Read More
https://www.entradatx.com/aboutSubdomain Learn More
/platformSubdomain Text duplicate Learn More
/pipelineSubdomain Text duplicate Learn More
https://www.entradatx.com/careersSubdomain Text duplicate Learn More
https://www.entradatx.com/careersText duplicate Open Positions
https://www.entradatx.com/careers2023 Best Places to Work Presented by Biospace - see our open positions
https://www.entradatx.com/careersBoston Globe Best Places to Work in Massachusetts 2023 - see our open positions
https://www.entradatx.com/careersWinner MassEcon Impact Award - see our open positions
https://www.entradatx.com/aboutSubdomain Who We Are Meet our leadership team
/platformSubdomain Platform Learn about our EEV™ Platform
/pipelineSubdomain Pipeline Discover our pipeline of programs
https://www.entradatx.com/careersSubdomain Careers Apply to our open positions
https://ir.entradatx.com/news-...External Subdomain Newsroom Read the latest press releases
https://www.entradatx.com/contactSubdomain Get in Touch Contact Entrada Therapeutics
https://www.entradatx.com/No Text
/privacy-policyText duplicate Privacy Policy
/terms-of-useText duplicate Terms of Use
/privacy-policyText duplicate Privacy Policy
/terms-of-useText duplicate Terms of Use
https://www.entradatx.com/New window OK

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.entradatx.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is slow (1.45 seconds). The response time should be less than 0.4 seconds. Slow websites are bad for search engine bots and also result in bad user experience.
The file size of the HTML document is very large (2,212 kB).

HTTP Response Header

NameValue
dateFri, 13 Sep 2024 11:15:53 GMT
content-typetext/html; charset=UTF-8
content-encodinggzip
link<https://www.entradatx.com>; rel='canonical'
permissions-policygeolocation=('self'); microphone=(); display-capture=(); camera=();
referrer-policyno-referrer-when-downgrade
strict-transport-securitymax-age=2592000
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
x-robots-tagall
x-xss-protection1; mode=block
cf-cache-statusDYNAMIC
servercloudflare
cf-ray8c27b8cdb8ea30d0-FRA
alt-svch3=":443"; ma=86400
statuscode200
http_versionHTTP/2

External factors

This website has excellent links from other websites.
This page has backlinks from 146 referring domains.
This page has 598 backlinks.
This page has backlinks from 137 different ip addresses.

Links from Wikipedia

No links from Wikipedia were found.

Robots.txt

# robots.txt for https://www.entradatx.com/

sitemap: https://www.entradatx.com/sitemaps-1-sitemap.xml

    # live - don't allow web crawlers to index cpresources/ or vendor/

    User-agent: *
    Disallow: /cpresources/
    Disallow: /vendor/
    Disallow: /.env
    Disallow: /cache/


# Disallow ChatGPT bot, as there's no benefit to allowing it to index your site
User-agent: GPTBot
Disallow: /

# Disallow Google Bard and Vertex AI bots, as there's no benefit to allowing it to index your site
User-agent: Google-Extended
Disallow: /

# Disallow Perplexity bot, as there's no benefit to allowing it to index your site
User-agent: PerplexityBot
Disallow: /

Similar sites

Search preview

www.entradatx.com
Entrada Therapeutics | Making Intracellular Therapeutics A Reality
Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
intracellular78%Check
Entrada74%Check
intracellular therapeutics73%Check
Making Intracellular73%Check
Entrada Therapeutics71%Check
Making Intracellular Therapeutics71%Check
therapeutics68%Check
Making63%Check
Reality62%Check
Entrada Therapeutics Announces61%Check
Show more keywords and terms

Test up to 1.000 webpages of entradatx.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions